Search filters

List of works by David R Owens

A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus.

scientific article published on 4 May 2017

Below Which Threshold of Glycemic Variability Is There a Minimal Risk of Hypoglycemia in People with Type 2 Diabetes?

scientific article published in 2022

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0.

scientific article published on 01 February 2019

Effect of structured self-monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study, a 12-month randomized controlled trial

scientific article published on 18 February 2019

Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes.

scientific article published on 27 April 2017

Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL

scientific article published on 07 November 2019

Future challenges and therapeutic opportunities in type 2 diabetes: Changing the paradigm of current therapy

scientific article

Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin-naive individuals with type 2 diabetes mellitus

scientific article published on 22 July 2018

The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications

scientific article published on 03 February 2020